3Martin J, Kelly D J, Mifsud SA,et al. Tranilast attenuates cardiac matrix deposition in experimental diabetes: role of transforming growth factor-β[ J]. Cardiovascular Research ,2005,65 (5) : 694-701.
4Podlesny M. Diabetic cardiomyopathy [ J ]. Pol Merkuriusz Lek, 2003,15(89) :476-479.
5Scognamiglio R, Negut C, de Krcuizenberg SV, et al. Abnormal mycardial perfusion and contractile recruitment during exercise in type 1 diabetic patients[J]. Clln Cardiol, 2005,28 (2) :93-99.
6Tscho PC, Walther T, Niger JK,et al. Prevention of cardiac fibrosis and left ventricular dysfunction in diabetic cardiomyopathy in rats by transgenic expression of the human tissue kallikrein gene [ J ]. FASEB J, 2004,18(12) :828-835.
8Lee SW, Song KE, Shin DS,et al. Alterations in peripheral blood levels of TIMP-1, MMP-2, and MMP-9 in patients with type-2 diabetes[ J]. Diabetes Res Clin Pract,2005,69 (2) : 175-179.
9Tayebjee MH, Lira MHS, Macfadyen MR J, et al. Matrix Metalloproteinase-9 and Tissue Inhibitor of Metalloproteinase-1 and -2 in Type 2 Diabetes [ J ]. Diabetes Care, 2004,27 ( 8 ) : 2049 -2051.
10Giebel SJ, Menicucci G, McGuire PG, et al. Matrix metalloproteinases in early diabetic retinopathy and their role in alteration of the blood-retinal barrier [ J ]. Lab Invest,2005,85 ( 5 ) : 597-607.
8Rubler S, Dlugash J, Yuceoglu YZ, et al. New type of cardiomyopathy associated with diabetic glomerulosclerosis[ J]. Am J Cardiol, 1972, 30(6) :595 -602.
